Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

223 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Phase I study of maytansine using a 3-day schedule.
Cabanillas F, Rodriguez V, Hall SW, Burgess MA, Bodey GP, Freireich EJ. Cabanillas F, et al. Among authors: burgess ma. Cancer Treat Rep. 1978 Mar;62(3):425-8. Cancer Treat Rep. 1978. PMID: 348310 Clinical Trial.
Clinical pharmacology of homoharringtonine.
Savaraj N, Lu K, Dimery I, Feun LG, Burgess M, Keating M, Loo TL. Savaraj N, et al. Cancer Treat Rep. 1986 Dec;70(12):1403-7. Cancer Treat Rep. 1986. PMID: 3791253
Phase I study of aziridinylbenzoquinone (NSC 182986).
Bedikian AY, Bodey GP, Burgess MA, Freireich EJ. Bedikian AY, et al. Among authors: burgess ma. Cancer Clin Trials. 1981 Winter;4(4):459-63. Cancer Clin Trials. 1981. PMID: 7318128
Doxorubicin-DNA complex: a phase I clinical trial.
Hall SW, Benjamin RS, Burgess MA, Bodey GP, Luna MA, Freireich EJ. Hall SW, et al. Among authors: burgess ma. Cancer Treat Rep. 1982 Dec;66(12):2033-7. Cancer Treat Rep. 1982. PMID: 7139645
223 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page